CGTX vs TFX · $120.8M cap vs P/E 2083, rev $1.12B
Cognition Therapeutics Inc (CGTX) versus Teleflex Incorporated (TFX) — a side-by-side from cached financials, not a winner call.
Cognition Therapeutics Inc (CGTX) is a biotechnology company listed on US.
Teleflex Incorporated (TFX) is a medical instruments & supplies company listed on NYSE.
CGTX does not have a complete income-statement cache yet.
Latest reported TFX revenue for 2026-06-30 was $1.12B. Net income was $91.5M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
CGTX currently screens at market cap $120.8M. TFX currently screens at market cap $5.53B and trailing P/E 2082.7.
Not investment advice. Open the CGTX and TFX stock pages for the full models.
Not investment advice.